• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟代脱氧葡萄糖正电子发射断层扫描(FDG PET-CT)检查中纵隔淋巴结转移假阳性的病理 N0 非小细胞肺癌患者的临床特征和预后。

Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT.

机构信息

Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Division of Nuclear Medicine, Department of Radiology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

In Vivo. 2021 May-Jun;35(3):1829-1836. doi: 10.21873/invivo.12444.

DOI:10.21873/invivo.12444
PMID:33910869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8193318/
Abstract

BACKGROUND/AIM: Preoperative fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET-CT) is a non-invasive and useful diagnostic tool to evaluate mediastinal lymph node (LN) metastasis in lung cancer. However, there are often false-positive LN cases in FDG PET-CT. This study aimed to explore the clinical characteristics and outcome of pathologic N0 non-small cell lung cancer patients with false-positive mediastinal LN on FDG PET-CT.

PATIENTS AND METHODS

We enrolled 147 patients who underwent preoperative FDG PET-CT scan and mediastinal LN dissection. These patients were re-evaluated for post-operative pathologic nodal metastasis and divided into a false-positive group and a group of others.

RESULTS

Among 40 patients diagnosed with clinical N1-3 on FDG PET-CT, 19 (47.5%) patients were pathologic N0, meaning false-positive LN by PET-CT. Preoperative absolute platelet count and platelet-lymphocyte ratio were significantly higher in patients with pathologic N0. The presence of lymphatic invasion was significantly lower in patients with pathologic N0 than in the group of others. Recurrence-free survival was significantly shorter in patients with false positive LN than in patients with true positive LN or true negative LN at the same pathologic stage.

CONCLUSION

Higher absolute platelet count and PLR, lower proportion of lymphatic invasion and shorter recurrence-free survival were associated with false positive mediastinal LN on preoperative FDG PET-CT.

摘要

背景/目的:氟-18 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET-CT)是一种非侵入性且有用的诊断工具,可用于评估肺癌纵隔淋巴结(LN)转移。然而,FDG PET-CT 中常有假阳性 LN 病例。本研究旨在探讨 FDG PET-CT 显示假阳性纵隔 LN 的病理 N0 非小细胞肺癌患者的临床特征和结局。

患者和方法

我们纳入了 147 例接受术前 FDG PET-CT 扫描和纵隔 LN 解剖的患者。这些患者术后均重新评估病理淋巴结转移情况,并分为假阳性组和其他组。

结果

在 40 例 FDG PET-CT 诊断为临床 N1-3 的患者中,19 例(47.5%)患者病理 N0,即 PET-CT 显示假阳性 LN。术前绝对血小板计数和血小板-淋巴细胞比值在病理 N0 患者中显著升高。与其他组相比,病理 N0 患者的淋巴血管侵犯发生率显著降低。在相同病理分期时,假阳性 LN 患者的无复发生存率明显短于真阳性 LN 或真阴性 LN 患者。

结论

术前 FDG PET-CT 显示假阳性纵隔 LN 与较高的绝对血小板计数和 PLR、较低的淋巴血管侵犯比例和较短的无复发生存率相关。

相似文献

1
Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET-CT)检查中纵隔淋巴结转移假阳性的病理 N0 非小细胞肺癌患者的临床特征和预后。
In Vivo. 2021 May-Jun;35(3):1829-1836. doi: 10.21873/invivo.12444.
2
The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.在肺部炎症性疾病患病率较高的地区,18F-氟脱氧葡萄糖正电子发射断层显像(FDG PET)成像在非小细胞肺癌术前分期中区分N0或N1期与N2期的附加价值。
Clin Nucl Med. 2007 Aug;32(8):607-12. doi: 10.1097/RLU.0b013e3180a1ac87.
3
The diagnostic ability of F-FDG PET/CT for mediastinal lymph node staging using F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.¹⁸F-FDG PET/CT利用¹⁸F-FDG摄取及容积CT直方图分析在非小细胞肺癌纵隔淋巴结分期中的诊断能力
Eur Radiol. 2016 Dec;26(12):4515-4523. doi: 10.1007/s00330-016-4292-8. Epub 2016 Mar 4.
4
Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.前瞻性正电子发射断层扫描-计算机断层扫描综合评估非小细胞肺癌患者术前纵隔淋巴结分期。
Eur J Cardiothorac Surg. 2009 Oct;36(4):731-6. doi: 10.1016/j.ejcts.2009.05.044. Epub 2009 Jul 25.
5
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.非小细胞肺癌患者正电子发射断层扫描淋巴结分期的陷阱
Lung Cancer. 2005 Feb;47(2):235-42. doi: 10.1016/j.lungcan.2004.08.004.
6
Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.基于 FDG PET/CT 的代谢参数对 cN2 期非小细胞肺癌患者淋巴结转移的诊断价值。
BMC Cancer. 2021 Sep 2;21(1):983. doi: 10.1186/s12885-021-08688-6.
7
PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.正电子发射断层显像-氟代脱氧葡萄糖(PET-FDG)扫描可强化但不能替代非小细胞肺癌的术前手术分期。
Eur J Cardiothorac Surg. 2001 Sep;20(3):468-74; discussion 474-5. doi: 10.1016/s1010-7940(01)00827-2.
8
Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the F-FDG PET/CT mediastinal nodal staging of non-small cell lung cancer.比较氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描纵隔淋巴结分期非小细胞肺癌时假阴性和真阳性淋巴结中 GLUT-1、SGLT-1 和 SGLT-2 的表达。
Lung Cancer. 2018 Sep;123:30-35. doi: 10.1016/j.lungcan.2018.06.004. Epub 2018 Jun 9.
9
Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.氟-18 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(¹⁸F-FDG PET/CT)与肿瘤标志物联合诊断非小细胞肺癌(NSCLC)淋巴结转移:回顾性和前瞻性研究。
Med Sci Monit. 2020 Jun 2;26:e922675. doi: 10.12659/MSM.922675.
10
[F]FAPI adds value to [F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study.FAPI 对Ⅰ-ⅡIA 期非小细胞肺癌淋巴结转移的诊断价值:一项前瞻性研究。
Cancer Imaging. 2024 Jun 3;24(1):68. doi: 10.1186/s40644-024-00701-y.

引用本文的文献

1
Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP.肺癌正电子发射断层显像(PET)及放射性配体疗法的最新进展:氟代脱氧葡萄糖(FDG)与成纤维细胞活化蛋白(FAP)
Cancers (Basel). 2025 Aug 1;17(15):2549. doi: 10.3390/cancers17152549.
2
CT features and histogram analysis of non-contrast images for differentiating malignant and benign mediastinal lymph nodes in Non-Small Cell Lung Cancer (NSCLC).非小细胞肺癌(NSCLC)中用于鉴别恶性和良性纵隔淋巴结的平扫CT图像特征及直方图分析
PLoS One. 2025 Apr 17;20(4):e0321921. doi: 10.1371/journal.pone.0321921. eCollection 2025.
3
Multimodal Framework in Lung Cancer Management: Integrating Liquid Biopsy with Traditional Diagnostic Techniques.肺癌管理中的多模态框架:将液体活检与传统诊断技术相结合。
Cancer Manag Res. 2025 Mar 3;17:461-481. doi: 10.2147/CMAR.S506630. eCollection 2025.
4
Mediastinal Staging in Non-Small-Cell Lung Cancer: Saying Goodbye to Mediastinoscopy.非小细胞肺癌纵隔分期:告别纵隔镜检查。
J Clin Oncol. 2023 Aug 1;41(22):3785-3790. doi: 10.1200/JCO.23.00867. Epub 2023 Jun 2.
5
Comparison of recurrence risk between patients with clinically node-positive and -negative stage I non-small cell lung cancer following surgery: A propensity score matching analysis.临床淋巴结阳性和阴性Ⅰ期非小细胞肺癌患者手术后复发风险的比较:倾向评分匹配分析。
Thorac Cancer. 2022 Jul;13(13):1933-1939. doi: 10.1111/1759-7714.14462. Epub 2022 May 17.

本文引用的文献

1
Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.肺癌 FDG-PET 假阳性淋巴结状态的临床病理意义。
Clin Lung Cancer. 2021 May;22(3):218-224. doi: 10.1016/j.cllc.2020.05.002. Epub 2020 May 14.
2
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.
3
Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion.升高的预处理血小板与淋巴细胞比值与伴恶性胸腔积液的 IV 期非小细胞肺癌患者的不良生存相关。
Sci Rep. 2019 Mar 18;9(1):4721. doi: 10.1038/s41598-019-41289-9.
4
PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1.ROS1 重排非小细胞肺癌中 PD-L1 的表达:同时进行 EGFR、ALK 和 ROS1 基因检测的研究。
Thorac Cancer. 2019 Jan;10(1):103-110. doi: 10.1111/1759-7714.12917. Epub 2018 Nov 26.
5
Indications for invasive mediastinal staging for non-small cell lung cancer.非小细胞肺癌侵袭性纵隔分期的指征
J Thorac Cardiovasc Surg. 2018 Dec;156(6):2319-2324. doi: 10.1016/j.jtcvs.2018.07.027. Epub 2018 Jul 21.
6
Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients.肺癌患者PET-CT扫描假阳性诊断的回顾性分析。
Medicine (Baltimore). 2017 Oct;96(42):e7415. doi: 10.1097/MD.0000000000007415.
7
Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.I期肺癌患者根治性切除术后肿瘤FDG摄取与血液学预后指标的关系
Medicine (Baltimore). 2017 Feb;96(5):e5935. doi: 10.1097/MD.0000000000005935.
8
Identification of false-negative and false-positive diagnoses of lymph node metastases in non-small cell lung cancer patients staged by integrated (18F-)fluorodeoxyglucose-positron emission tomography/computed tomography: A retrospective cohort study.基于整合(18F-)氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的非小细胞肺癌患者淋巴结转移分期中假阴性和假阳性诊断的鉴定:一项回顾性队列研究。
Thorac Cancer. 2016 Jul;7(4):473-80. doi: 10.1111/1759-7714.12358. Epub 2016 May 5.
9
Epidemiology of Lung Cancer in Korea: Recent Trends.韩国肺癌流行病学:近期趋势
Tuberc Respir Dis (Seoul). 2016 Apr;79(2):58-69. doi: 10.4046/trd.2016.79.2.58. Epub 2016 Mar 31.
10
Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.血小板与淋巴细胞比值在非小细胞肺癌中的预后作用:一项纳入3720例患者的荟萃分析。
Int J Cancer. 2016 Jul 1;139(1):164-70. doi: 10.1002/ijc.30060. Epub 2016 Mar 24.